Key Benefits of GLP-1 Medical Weight Loss Clinically proven results Semaglutide clinical trials showed average weight loss of 14.9% of body weight over 68 weeks (STEP 1 trial, published in the New England Journal of Medicine , 2021)
Rybelsus 14 mg Tablet Summary of Product Characteristics (SmPC)
Filip Krag Knop has served on scientific advisory panels and/or been part of speakers bureaus for, served as a consultant to, and/or received research support from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Carmot Therapeutics, Eli Lilly, Gubra, MedImmune, MSD/Merck, Mundipharma, Norgine, Novo Nordisk, Sanofi, and Zealand Pharma
Review your progress and goals Adjust nutrition to maintain results Increase physical activity Monitor appetite and habits Stay consistent with support systems What Recrea Health resources can help
Semaglutide weight loss has become the answer for many who struggled with traditional approaches